ATE283357T1 - Tumor-suppressorgen del-27 und das dadurch kodierte protein, verfahren zu deren herstellung und nutzung - Google Patents
Tumor-suppressorgen del-27 und das dadurch kodierte protein, verfahren zu deren herstellung und nutzungInfo
- Publication number
- ATE283357T1 ATE283357T1 AT99103157T AT99103157T ATE283357T1 AT E283357 T1 ATE283357 T1 AT E283357T1 AT 99103157 T AT99103157 T AT 99103157T AT 99103157 T AT99103157 T AT 99103157T AT E283357 T1 ATE283357 T1 AT E283357T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- dna
- coded
- del
- stringent conditions
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000044209 Tumor Suppressor Genes Human genes 0.000 title 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 6
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004414 DNA Proteins 0.000 abstract 2
- 230000004663 cell proliferation Effects 0.000 abstract 2
- 108091029865 Exogenous DNA Proteins 0.000 abstract 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 abstract 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 230000002100 tumorsuppressive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98103334A EP0943682A1 (de) | 1998-02-26 | 1998-02-26 | Tumor-Suppressor Gen Del-27 und das dadurch kodierte Protein, Verfahren zu deren Herstellung und Nutzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE283357T1 true ATE283357T1 (de) | 2004-12-15 |
Family
ID=8231478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99103157T ATE283357T1 (de) | 1998-02-26 | 1999-02-18 | Tumor-suppressorgen del-27 und das dadurch kodierte protein, verfahren zu deren herstellung und nutzung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20020004232A1 (de) |
| EP (2) | EP0943682A1 (de) |
| JP (1) | JP3503928B2 (de) |
| AT (1) | ATE283357T1 (de) |
| AU (1) | AU713469B2 (de) |
| CA (1) | CA2261964C (de) |
| DE (1) | DE69922071T2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0031276D0 (en) * | 2000-12-21 | 2001-01-31 | Inpharmatica Ltd | Novel protein |
| US6461843B1 (en) * | 2001-02-16 | 2002-10-08 | Applera Corporation | Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4889806A (en) * | 1987-04-15 | 1989-12-26 | Washington University | Large DNA cloning system based on yeast artificial chromosomes |
| EP0784096A1 (de) * | 1996-01-10 | 1997-07-16 | Boehringer Mannheim Gmbh | Verfahren zum Nachweis von Polymorphismus und Heterozygotieverlust in einem Lungentumor-Suppressor-Gen |
-
1998
- 1998-02-26 EP EP98103334A patent/EP0943682A1/de not_active Withdrawn
-
1999
- 1999-02-18 DE DE69922071T patent/DE69922071T2/de not_active Expired - Fee Related
- 1999-02-18 EP EP99103157A patent/EP0939126B1/de not_active Expired - Lifetime
- 1999-02-18 AT AT99103157T patent/ATE283357T1/de not_active IP Right Cessation
- 1999-02-22 JP JP04376099A patent/JP3503928B2/ja not_active Expired - Fee Related
- 1999-02-24 CA CA002261964A patent/CA2261964C/en not_active Expired - Fee Related
- 1999-02-25 AU AU18420/99A patent/AU713469B2/en not_active Ceased
-
2001
- 2001-01-26 US US09/771,404 patent/US20020004232A1/en not_active Abandoned
-
2002
- 2002-10-03 US US10/263,316 patent/US20030059825A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0939126B1 (de) | 2004-11-24 |
| US20030059825A1 (en) | 2003-03-27 |
| EP0943682A1 (de) | 1999-09-22 |
| JPH11276183A (ja) | 1999-10-12 |
| JP3503928B2 (ja) | 2004-03-08 |
| DE69922071T2 (de) | 2005-12-15 |
| AU713469B2 (en) | 1999-12-02 |
| CA2261964A1 (en) | 1999-08-26 |
| US20020004232A1 (en) | 2002-01-10 |
| EP0939126A1 (de) | 1999-09-01 |
| AU1842099A (en) | 1999-09-09 |
| DE69922071D1 (de) | 2004-12-30 |
| CA2261964C (en) | 2002-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2346951C2 (ru) | Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты) | |
| KR880014110A (ko) | 인체 프로아포지방단백질 a-i의 발현 | |
| ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| NO173741C (no) | DNA-sekvens for modifisert protein C, vektor inneholdende denne, patte-dyrceller transfektert med vektorer, og fremgangsmaate for fremstilling av nevnte protein | |
| ATE309342T1 (de) | Verfahren zur herstellung in vitro von rekombinierten nucleotidsequenzen, und so hergestelte genbanken und sequenzen | |
| HK49285A (en) | Interferons and process for their preparation | |
| DK1025211T3 (da) | Hyaluronansyntasegen og anvendelser deraf | |
| KR970701199A (ko) | 성장 정지 호메오박스 유전자(Growth Arrest Homeobox Gene) | |
| ATE315087T1 (de) | Neuartige auf p53 ansprechende gene | |
| AU7891498A (en) | Flower organ-specific gene and its promoter sequence | |
| CA2091102A1 (en) | Microsomal triglyceride transfer protein | |
| ATE93272T1 (de) | Expression von protein c. | |
| KR960010863A (ko) | 재조합 머사시딘 및 이의 제조방법 | |
| EP0139501A3 (de) | Herstellung und Expression von Genen für Thaumatin | |
| ATE283357T1 (de) | Tumor-suppressorgen del-27 und das dadurch kodierte protein, verfahren zu deren herstellung und nutzung | |
| WO1995032297B1 (en) | Novel chromosome fragment and its use as a vector | |
| IL116019A0 (en) | Nucleic acids coding for penicillin v amidohydrolase expression vectors and host cells containing the same and methods for the production thereof | |
| NZ332586A (en) | Suppression of endogenous gene and replacement of suppressed gene sequence | |
| EP1277837A3 (de) | Epididymis-spezifische DNA-Sequenzen und deren Verwendung | |
| IL144648A0 (en) | Heat-inducible promoter | |
| DK0805204T3 (da) | Bitestikel - specifikt receptorprotein og anvendelse heraf | |
| WO2002010384A1 (en) | Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin | |
| AU4917300A (en) | Method for producing a recombinant protein | |
| DE69031996D1 (de) | Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung | |
| DE3882455D1 (de) | Verfahren zur herstellung von proteinen in loeslicher form. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |